Global Pharma Industry FAQs
What are the current challenges to the industry?
Undoubtedly the research-based pharmacuetical industry is facing an increasingly hostile operating environment. The burden of regulation continues to grow. The contentious area of medical economics and patient outcome assessment has armed health payers with information to challenge prices and limit a product’s revenue potential.

The rise in the number of products failing to move from Phase III to market is now as much about economics as it is about safety and efficacy. This has further impacted the already limited number of novel products coming to market and is the root of much commentator despondency.

What are the opportunities for the industry?
Easy as it might be to see the gloomy side, there is a real basis for optimism. The fact is that there is considerable unmet clinical need and many of the world’s major diseases can only partially be controlled. In addition, social trends are causing a rapid expansion in key disease areas, such as diabetes and asthma, while the global market for higher price gene-based therapies is expanding as emerging economies gain strength.

4D Pharma FAQs
How are 4D Pharma reports researched?
4D Pharma reports are written by a dedicated full-time team of pharmacists and biologists who collectively provide over 25 years experience of company analysis. Espicom only uses primary source material and is in continuing contact with companies. The forecasts in 4D Pharma are robust and statistically verified, taking into account a number of key business drivers and dampeners. Direct industry access allied to thoughtful analysis of developments means our reputation for comprehensive and insightful coverage has been well earned.

What formats are available?
4D Pharma reports are available over the web or pdf by email or in print – the choice is yours.

What is the cost of a 4D Pharma report?
Single 4D pharma reports cost £595/US$1,130/€895 each for print by post, pdf by email or an annual single user web access account.

Can I buy discounted packages?
You can buy any combination of 4D Pharma company reports that are of interest to you cost-effectively. Volume discounts apply – for example any three reports will cost £1,595/US$3,030/€2,375 a saving of £190/US$360/€290 on the single report price.

To discuss your requirements please contact Victoria McVeigh by email victoria_mcveigh@espicom.com or by telephone +44 (0) 1243 756027.

What are the benefits of 4D reports over the web?
The web version of 4D Pharma provides a number of benefits with an easy-to-use interface that allows fast access to the data via fast navigation or full text search. All the usual features of web access such as immediate update, instant access, cut and paste are available. Importantly, all the reports you purchase can be viewed from the same access page and the search function delivers results from all your reports ensuring a comprehensive display of results and saving your business a considerable amount of research time.

Are multi-user web access accounts available for 4D Pharma reports?
Yes multi-user web access accounts are available. Discounts for companies and organisations that want to have multi-user web access to 4D Pharma reports make this a cost effective option.

I have specific information needs – can you help?
Using our innovative access technology we are able to provide selections of data from our full range of business intelligence products – from detailed therapy assessments through to daily updated news – in bespoke packages for you and your colleagues.

For a no-commitment discussion and demonstration, please contact Victoria McVeigh by email victoria_mcveigh@espicom.com or telephone +44 (0) 1243 756027 or through our contact form.